Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis

被引：0
|
作者：
An-ju Tan
Dun-chang Mo
Ka Wu
Hong-mei Pan
Dong-mei Wang
Xing-xin Xu
Min-hong Chen
Shu-ying Pan
Rou Li
Wen-jiao lian
Meng-han Wei
机构：
[1] The Third Affiliated Hospital of Guangxi Medical University,Department of pharmacy
[2] The Third Affiliated Hospital of Guangxi Medical University,Radiotherapy Department
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Combination immunotherapy; Immune checkpoint inhibitor; Renal cell carcinoma; Meta-analysis; Nephrotoxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1563 / 1571
页数：8
相关论文
共 50 条
  • [1] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    Tan, An-ju
    Mo, Dun-chang
    Wu, Ka
    Pan, Hong-mei
    Wang, Dong-mei
    Xu, Xing-xin
    Chen, Min-hong
    Pan, Shu-ying
    Li, Rou
    Lian, Wen-jiao
    Wei, Meng-han
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1563 - 1571
  • [2] Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients
    Yuxuan Song
    Songchen Han
    Tao Xu
    World Journal of Urology, 2023, 41 : 1991 - 1992
  • [3] Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients
    Song, Yuxuan
    Han, Songchen
    Xu, Tao
    WORLD JOURNAL OF UROLOGY, 2023, 41 (07) : 1991 - 1992
  • [4] Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis
    Feng, Yao-Ning
    Xie, Guang-Yu
    Xiao, Li
    Mo, Dun-Chang
    Huang, Jian-Feng
    Luo, Peng-Hui
    Liang, Xiu-Juan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Efficacy and toxicity of immune checkpoint inhibitors combination therapy for advanced renal cell carcinoma: a systematic review and network meta-analysis
    Chen, Xiangyu
    Xu, Zhunan
    Wu, Changgui
    Xie, Lijun
    Wang, Pengyu
    Liu, Xiaoqiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Takagi, Toshio
    TARGETED ONCOLOGY, 2023, 18 (01) : 159 - 168
  • [7] Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
    Hiroki Ishihara
    Yuki Nemoto
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Tsunenori Kondo
    Toshio Takagi
    Targeted Oncology, 2023, 18 : 159 - 168
  • [8] Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
    Gu, Yi-Min
    Shang, Qi-Xin
    Zhuo, Yue
    Zhou, Jian-Feng
    Liu, Bo-Wei
    Wang, Wen-Ping
    Che, Guo-Wei
    Chen, Long-Qi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma
    Ishihara, Hiroki
    Nishimura, Koichi
    Ikeda, Takashi
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kondo, Tsunenori
    Takagi, Toshio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 291e27 - 291e37
  • [10] Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis
    Su, Jingyang
    Zhang, Jialin
    Wu, Yuqian
    Ni, Cui
    Ding, Yueyue
    Cai, Zelin
    Xu, Ming
    Lai, Mingyang
    Wang, Jue
    Lin, Shengyou
    Lu, Jinhua
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345